CELEX: 62017TA0804
Language: en
Date: 2019-04-04 00:00:00
Title: Case T-804/17: Judgment of the General Court of 4 April 2019 — Stada Arzneimittel v EUIPO (Representation of two facing arches) (EU trade mark — Application for an EU figurative mark representing two facing arches — Absolute ground for refusal — Lack of distinctive character — Article 7(1)(b) of Regulation (EC) No 207/2009 (now Article 7(1)(b) of Regulation (EU) 2017/1001))

20.5.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 172/33
            
         
      Judgment of the General Court of 4 April 2019 — Stada Arzneimittel v EUIPO (Representation of two facing arches)
      (Case T-804/17) (1)
      
      (EU trade mark - Application for an EU figurative mark representing two facing arches - Absolute ground for refusal - Lack of distinctive character - Article 7(1)(b) of Regulation (EC) No 207/2009 (now Article 7(1)(b) of Regulation (EU) 2017/1001))
      (2019/C 172/45)
      Language of the case: German
      
         Parties
      
      
         Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: J.-C. Plate and R. Kaase, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented initially by D. Hanf and D. Walicka and subsequently by D. Hanf and E. Markakis, acting as Agents)
      
         Re:
      
      Action brought against the decision of the First Board of Appeal of EUIPO of 20 September 2017 (Case R 1887/2016-1) relating to an application for registration of a figurative sign representing two facing arches as an EU trade mark.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  
                     Dismisses the action;
                  
               
            
                  2.
               
               
                  
                     Orders Stada Arzneimittel AG to pay the costs.
                  
               
            
         (1)  OJ C 42, 5.2.2018.